172 related articles for article (PubMed ID: 24414886)
1. Assessment of active pharmaceutical ingredient particle size in tablets by Raman chemical imaging validated using polystyrene microsphere size standards.
Kuriyama A; Ozaki Y
AAPS PharmSciTech; 2014 Apr; 15(2):375-87. PubMed ID: 24414886
[TBL] [Abstract][Full Text] [Related]
2. Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: a progress report.
Doub WH; Adams WP; Spencer JA; Buhse LF; Nelson MP; Treado PJ
Pharm Res; 2007 May; 24(5):934-45. PubMed ID: 17372686
[TBL] [Abstract][Full Text] [Related]
3. Drug characterization in low dosage pharmaceutical tablets using Raman microscopic mapping.
Henson MJ; Zhang L
Appl Spectrosc; 2006 Nov; 60(11):1247-55. PubMed ID: 17132441
[TBL] [Abstract][Full Text] [Related]
4. Raman mapping of low-content API pharmaceutical formulations. I. Mapping of Alprazolam in Alprazolam/Xanax tablets.
Sasić S
Pharm Res; 2007 Jan; 24(1):58-65. PubMed ID: 17048116
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the determination of a low-concentration active ingredient in pharmaceutical tablets by backscatter and transmission Raman spectrometry.
Townshend N; Nordon A; Littlejohn D; Myrick M; Andrews J; Dallin P
Anal Chem; 2012 Jun; 84(11):4671-6. PubMed ID: 22533444
[TBL] [Abstract][Full Text] [Related]
6. Multi-layer Raman chemical mapping to investigate the effect of API particle size and blending shear rate on API domain sizes in pharmaceutical tablets.
Gupta S; Igne B; Omar T; Román-Ospino AD; Hausner D; Muzzio F
Int J Pharm; 2022 Aug; 624():122052. PubMed ID: 35902051
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Raman and Near-Infrared Chemical Mapping for the Analysis of Pharmaceutical Tablets.
Carruthers H; Clark D; Clarke F; Faulds K; Graham D
Appl Spectrosc; 2021 Feb; 75(2):178-188. PubMed ID: 32757763
[TBL] [Abstract][Full Text] [Related]
8. Performance assessment of linear iterative optimization technology (IOT) for Raman chemical mapping of pharmaceutical tablets.
Gupta S; Román-Ospino AD; Baranwal Y; Hausner D; Ramachandran R; Muzzio FJ
J Pharm Biomed Anal; 2021 Oct; 205():114305. PubMed ID: 34385017
[TBL] [Abstract][Full Text] [Related]
9. Raman chemical mapping of low-content active pharmaceutical ingredient formulations. III. Statistically optimized sampling and detection of polymorphic forms in tablets on stability.
Šašić S; Mehrens S
Anal Chem; 2012 Jan; 84(2):1019-25. PubMed ID: 22191712
[TBL] [Abstract][Full Text] [Related]
10. Measuring Bismuth Oxide Particle Size and Morphology in Film-Coated Tablets.
Fertaki S; Bagourakis G; Orkoula M; Kontoyannis C
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458800
[TBL] [Abstract][Full Text] [Related]
11. Topologically directed confocal Raman imaging (TD-CRI): Advanced Raman imaging towards compositional and micromeritic profiling of a commercial tablet components.
Muthudoss P; Kumar S; Ann EYC; Young KJ; Chi RLR; Allada R; Jayagopal B; Dubala A; Babla IB; Das S; Mhetre S; Saraf I; Paudel A
J Pharm Biomed Anal; 2022 Feb; 210():114581. PubMed ID: 35026592
[TBL] [Abstract][Full Text] [Related]
12. Fiber-Array-Based Raman Hyperspectral Imaging for Simultaneous, Chemically-Selective Monitoring of Particle Size and Shape of Active Ingredients in Analgesic Tablets.
Frosch T; Wyrwich E; Yan D; Popp J; Frosch T
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801249
[TBL] [Abstract][Full Text] [Related]
13. Microencapsulation of a hydrophilic drug into a hydrophobic matrix using a salting-out procedure. II. Effects of adsorbents on microsphere properties.
Mani N; Suh HR; Jun HW
Drug Dev Ind Pharm; 2004 Jan; 30(1):83-93. PubMed ID: 15000433
[TBL] [Abstract][Full Text] [Related]
14. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
15. Raman mapping of low-content active-ingredient pharmaceutical formulations. part II: statistically optimized sampling for detection of less than 1% of an active pharmaceutical ingredient.
Sasić S; Whitlock M
Appl Spectrosc; 2008 Aug; 62(8):916-21. PubMed ID: 18702866
[TBL] [Abstract][Full Text] [Related]
16. Calibration transfer between modelled and commercial pharmaceutical tablet for API quantification using backscattering NIR, Raman and transmission Raman spectroscopy (TRS).
Wang X; Mao DZ; Yang YJ
J Pharm Biomed Anal; 2021 Feb; 194():113766. PubMed ID: 33280998
[TBL] [Abstract][Full Text] [Related]
17. Selective detection of active pharmaceutical ingredients in tablet formulations using solid-state NMR spectroscopy.
Hong YL; Manjunatha Reddy GN; Nishiyama Y
Solid State Nucl Magn Reson; 2020 Apr; 106():101651. PubMed ID: 32058901
[TBL] [Abstract][Full Text] [Related]
18. Application of Raman microscopy and band-target entropy minimization to identify minor components in model pharmaceutical tablets.
Widjaja E; Seah RK
J Pharm Biomed Anal; 2008 Jan; 46(2):274-81. PubMed ID: 17980994
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of drug physical form during granulation, tabletting and storage.
Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
[TBL] [Abstract][Full Text] [Related]
20. Improving Diameter Accuracy for Dynamic Imaging Microscopy for Different Particle Types.
Cavicchi RE; Ripple DC;
J Pharm Sci; 2020 Jan; 109(1):488-495. PubMed ID: 31628920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
